TripleFive Pilot Study investigating the feasibility and initial safety of the application of the haemostatic sponge ACF-Matrix haemostat in 10 Coronary Artery Bypass Grafting patients.
Recruiting
- Conditions
- CABG surgery
- Registration Number
- NL-OMON22988
- Lead Sponsor
- Gelita Medical
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 10
Inclusion Criteria
1. Patients 18 years or older;
2. Patients demonstrating signs and symptoms of coronary ischaemia and/or stenosis clinically considered suitable for correction by CABG surgery;
Exclusion Criteria
1. Patients coming in for an emergency CABG procedure;
2. Patients coming in for a re- CABG procedure;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method o unexpected post operative events in blood chemistry and no clinical signs and symptoms of tamponade.
- Secondary Outcome Measures
Name Time Method Reduced post operative blood and fluid loss produced by the drains.